|
J Biol Chem, Vol. 275, Issue 10, 7198-7204, March 10, 2000
Functional Domain Mapping and Subcellular Distribution of
Dal82p in Saccharomyces cerevisiae*
Stephanie
Scott,
Rosemary
Dorrington ,
Vladimir
Svetlov§,
Alexander E.
Beeser,
Mackenzie
Distler, and
Terrance G.
Cooper¶
From the Department of Microbiology and Immunology, University of
Tennessee, Memphis, Tennessee 38163
 |
ABSTRACT |
Previous studies have shown that (i) Dal81p and
Dal82p are required for allophanate-induced gene expression in
Saccharomyces cerevisiae; (ii) the cis-acting
element mediating the induced transcriptional response to allophanate
is a dodecanucleotide, UISALL; and (iii) Dal82p
binds specifically to UISALL. Here we show that
Dal82p is localized to the nucleus and parallels movement of the DNA
through the cell cycle. Deletion analysis of DAL82 identified and localized three functional domains. Electrophoretic mobility shift assays identified a peptide (consisting of Dal82p amino
acids 1-85) that is sufficient to bind a DNA fragment containing UISALL. LexA-tethering experiments demonstrated
that Dal82p is capable of mediating transcriptional activation. The
activation domain consists of two parts: (i) an absolutely required
core region (amino acids 66-99) and (ii) less well defined regions flanking residues 66-99 that are required for full wild-type levels of
activation. The Dal82p C terminus contains a predicted coiled-coil motif that down-regulates Dal82p-mediated transcriptional activation.
 |
INTRODUCTION |
The Saccharomyces cerevisiae allantoin degradative
pathway genes can be classified according to one of three hierarchical control mechanisms. The first and least complex of these mechanisms is
exemplified by the allantoin permease gene (DAL5), which is subject only to nitrogen catabolite repression
(NCR)1 (1-5). NCR is the
physiological process through which the expression of genes encoding
proteins needed for the transport and catabolism of poor nitrogen
sources is maintained at low levels when a good nitrogen source is
available (6, 7). This process is the preeminent and most well
characterized mode of regulation for nitrogen catabolic genes (8, 9).
NCR is implemented by the regulation of Gln3p and Gat1p, the
transcriptional activators responsible for the expression of
NCR-sensitive genes (5, 10-18). Both Gln3p and Gat1p are predicted to
contain C4 zinc-finger motifs and are members of the GATA family of
DNA-binding proteins, and Gln3p binds to GATA-containing
UASNTR sequences situated upstream of NCR-sensitive genes
(12, 16, 19-21). Similar binding experiments have not so far been
performed with Gat1p due to its toxicity in Escherichia
coli.
The second control mechanism is exemplified by the DAL3
gene, whose expression, like that of DAL5, is NCR-sensitive
and dependent upon Gln3p (19, 20). In addition, however, this gene is
down-regulated by Dal80p, i.e. DAL3 expression
increases ~20-fold when DAL80 is deleted (16, 20). Dal80p
and its homologue, Deh1p, are also GATA family DNA-binding proteins
that bind to the GATA sequences of the genes whose expression they
regulate and that contain leucine zipper motifs at their C termini
(20-23). The Dal80p-binding site differs from that of Gln3p in that
Dal80p binding requires two specifically oriented GATA sequences,
whereas for Gln3p binding, only one GATA sequence is necessary (16,
24). The demonstration that Gln3p and Dal80p are capable of binding to
the same DAL3 GATA sequences led to the proposal that Dal80p
regulates Gln3p- and Gat1p-dependent gene expression by
competing with these transcriptional activators for binding to GATA
sequences in the promoters of Dal80p-regulated genes (20, 25).
Consistent with this proposal, we have shown that the level of nitrogen
catabolic gene expression and NCR sensitivity is related to the amounts
of Gat1p and Dal80p produced in the cell.2
The third and most complex allantoin pathway control mechanism is
exemplified by DAL7, encoding malate synthase (26-28).
DAL7 expression is NCR-sensitive; Gln3p- and
Gat1p-dependent, like that of DAL5; and
Dal80p-regulated, like that of DAL3 (17, 26). Superimposed
on these two forms of regulation is a third layer of control, which
occurs in response to the allantoin pathway inducer, allophanate, or
its analogue, oxalurate (26, 27). Inducer-responsive DAL7
expression depends upon a cis-acting element, the
allophanate-responsive upstream
induction sequence,
UISALL (26). One or more copies of this
dodecanucleotide element are found in the promoters of all
allophanate-responsive genes, both in the allantoin pathway as well as
in others such as CAR2 (29). Saturation mutagenesis of the
3' most DAL7 UISALL element demonstrated the
sequence of UISALL to be
5'-(G/C)AAA(A/T)NTGCG(T/C)T (30). A single copy of this element,
although sufficient for inducer responsiveness, will not alone support
heterologous gene expression; multiple copies will, however, support
very low level expression (26).
Two transcription factors are required for the
UISALL-mediated gene expression, Dal81p/DurMp
and Dal82p/DurLp/Uga35p (31, 32). DAL81 and DAL82
were first identified genetically as loci required for growth with
allantoin pathway nitrogen sources (31, 33). Null mutations in either
of the loci result in loss of allophanate-dependent
transcription (34, 35). Mutations in dal81 or
dal82 also result in a significant decrease in basal level
expression of the genes they regulate (35-37).
Initially, the best candidate to function as the
UISALL-binding protein was the 109-kDa Dal81p
because it possesses a Cys6(Zn+2)2
binuclear cluster motif (36). Enthusiasm for this candidacy quickly
diminished, however, when Dal81p was found to function beyond the
bounds of the allantoin pathway, e.g.
inducer-dependent expression of the -aminobutyrate genes
(32, 36). In addition, deletion of the Dal81p zinc-finger motif does
not affect allophanate-responsive gene expression (36). These results
focused our attention on the much smaller 29-kDa Dal82p as the
UISALL-binding transcription factor. Using
electrophoretic mobility shift assays (EMSAs), Dorrington and Cooper
(38) demonstrated that Dal82p specifically binds to
UISALL elements from all of the
allophanate/oxalurate-responsive allantoin pathway genes. It has also
recently been shown to bind to the UISALL
element upstream of CAR2 (29).
Experiments using cis-acting elements cloned into
heterologous expression vector assay systems demonstrated that both
Dal82p and Dal81p are required for the UIS element to
mediate inducer-dependent transcription (34, 35). However,
Dal82p possesses capabilities that depend upon neither inducer nor
Dal81p. For example, if a UISALL element is
placed adjacent to a mutated GATA sequence, it will efficiently
suppress the phenotype of that cis-acting mutation (30).
Suppression requires only a functional UISALL element and Dal82p, not inducer or Dal81p (30). In another situation, UISALL and Dal82p act together with Rap1p to
constitute a strong upstream activation sequence in the CAR2
promoter (29). Again, neither Dal81p nor allophanate/oxalurate are
required for this function. The pertinence of these two examples is
their highlighting that Dal82p can bind to DNA and perform some
functions in the absence of inducer or Dal81p.
Although much is known about the participation of Dal82p in
transcription, little is known about how the functions of this small
protein are carried out. Unfortunately, homology analyses of the
deduced Dal82p amino acid sequence have not provided insights or hints
in this regard. The only clearly recognizable motif is a predicted
coiled-coil at the C terminus of Dal82p. DNA-binding motifs similar to
those reported for other transcription factors are not apparent in
Dal82p. In fact, the transcriptional activation ability of Dal82p has
not been tested. The objective of this work has been to
identify the component functions of Dal82p and the portions of the
protein required to fulfill them.
 |
MATERIALS AND METHODS |
Strains and Media--
The strains used in this work are listed
in Table I. The media were standard
formulations with the pertinent details described below and in the
figure legends.
Construction of GAL1,10-GFP pNVS2--
To construct
GAL1,10-GFP pNVS2, the NdeI site in pRS316 (39)
was blunt-ended to yield pAB52. A GAL1,10
XbaI-XhoI PCR fragment (containing promoter and ATG)
was cloned into pAB52 to yield pAB53. Primers were
5'-GCTCTAGACCTTCTCTTTGGAACTTTCAGTAA-3' and
5'-CCGGCCCTCGAGCATTATAGTTTTTTCTCC-3', and the template was pEGKG (40).
PCR-generated GFP
(5'-ATGCTCGAGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTCCCC-3' and
5'-GGGGTACCATCGATAAGCTTCTGCAGGTCGACGGATCCCCCGGGGAATTCATTCAGTCATATGCTTGTACAGCTTGTCCATGCCGAGAGTGATCCCGGA-3' primers and pJ22 as template (41)) was cloned into pAB53. A clone
that fluoresced in a galactose-dependent manner, pNVS2, was
isolated, verified, and used.
GFP-DAL82 Plasmids--
The EcoRI-SalI
fragment from pSS82BTM (N-terminal segment of Dal82p) was cloned into
pNVS2. A pMO8 (34) SalI-HindIII fragment (remainder of Dal82p) was cloned into the resulting plasmid to yield
pNVS82. HIS3-based ADH1-GFP p423 was constructed
by replacing the XbaI-XhoI fragment (encoding the
GAL1,10 promoter) from pNVS2 with an ADH1
promoter XbaI-XhoI PCR fragment
(5'-GCGTCTAGAAAGAAATGATGGTAAATGAAATAGG-3' and
5'-GCGCTCGAGCATAGTTGATTGTATGCTTGGTATAGCTT-3' primers and pEG202 (45, 46) as template). The SacI-EcoRI fragment
from the resulting plasmid was then cloned into pRS423 (43) to yield
p423. Next, the EcoRI-ClaI fragment from pNVS82
was cloned into p423, and finally, the 0.5-kilobase pair
EcoRI fragment from pNVS82 was cloned into the resulting
plasmid to yield ADH1-GFP-DAL82 pSS423-82. To construct
positive control pSS20 for dal82 complementation (urea
amidolyase) assays, the pMO8 (34) EagI-ClaI
fragment (full-length DAL82 and its promoter) was cloned
into YCp50.
dal82 Mutant Strains--
The DAL82
EagI-HindIII fragment (from pMO8) was cloned into
pBluescript KS+ (Stratagene). The
BamHI-EcoRI fragment from this plasmid was replaced with the TRP1,Knr
BamHI-EcoRI fragment from pJA52 (42). Strain
TCY31 was transformed with the resulting plasmid (Asp718I-
and ClaI-digested). A Trp+ transformant (SS400)
was isolated and verified by Southern analysis. A dal82
disruption (SS200) was constructed by inserting the
HisG:URA3:HisG pNKY51 fragment (44) into the DAL82
BamHI site of pSS20. Strain SS200 was 5-FOA-selected after TCY31
cells were transformed with the linearized plasmid (Asp718I
and SphI) and verified by Southern analysis.
dal82 Deletion Plasmids--
DAL82 deletions were
constructed by cloning WT DAL82 into pSelect (Promega). For
each deletion, oligonucleotides were prepared such that they
encompassed 20 base pairs preceding and following the designated
deletion. After annealing and transformation into E. coli,
several colonies were screened by sequence
analysis. Clones containing the desired
deletions were used to replace WT sequences in pRD41 (Fig. 1) (23).
These plasmids (Fig. 2) were used to
prepare E. coli extracts for EMSAs. pRD4 contains the NdeI-BamHI fragment (9-amino acid influenza
hemagglutinin (HA) epitope) and Factor Xa recognition sequence fused to
Dal82p amino acids 1-6; pRD41 contains full-length DAL82 in
place of amino acids 1-6 (Fig. 1) (38). pRD403 carries the same
HA-DAL82 as pRD41, except that two NdeI sites (5'
of the AUG start codon of the HA epitope and 3' of DAL82)
were destroyed, leaving one NdeI site within
DAL82. pRD42, pRD43, and pRD44 were created from pRD41 by
deleting the StyI-HindIII,
XhoI-HindIII, and
EcoRI-HindIII fragments, respectively (Fig. 1);
sequence extensions were filled in and religated. pRD46 was constructed
by replacing the WT BamHI-EcoRI fragment from
pRD403 with a PCR product (pRD41 template and primers RD21 and RD22)
(Table II). pRD47 and pRD48 were
similarly constructed with PCR primers T7-7/RD24 and T7-7/RD26,
respectively. pRD476 is pRD403 with 1) the HindIII site at
the 3'-end of DAL82 destroyed; 2) a G-to-T substitution in
codon L78 (CTG to CTT), creating a unique
HindIII site; 3) a G-to-A substitution
(G116-R116), creating a unique StuI
site; and 4) deletion of residues 81-114. pRD477, pRD478, pRD479,
pRD480, pRD481, and pRD482 were constructed by cloning oligonucleotides
RD39, RD42, RD38, RD41, RD40, and RD37 (Table II), respectively, into
the HindIII-StuI site of pRD476. For pRD488 and
pRD489, the WT BamHI-NdeI fragment from pRD403 was replaced with oligonucleotides RD57 and RD58 (Table II). pRD402 is
a pRD403 derivative in which the StyI-HindIII
fragment is deleted; sequence extensions were filled in and relegated.
For pRD490, the WT NdeI-SalI fragment was
replaced with oligonucleotide RD59.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 1.
Plasmids used in this work:
GFP pNVS2, GFP-DAL82 (inset
below pNVS82), HA-DAL82 pRD41 (used to construct
dal82 in EMSAs), and lexA-DAL82
activation measurements.ORI, origin;
Kb, kilobase pairs; ADH prom., alcohol
dehydrogenase promoter; EGFP, enhanced GFP.
|
|
lexA-DAL82 Plasmids--
lexA-DAL82 p8202 was
constructed by cloning the 1.5-kilobase pair pMO8 (34)
BamHI-BamHI fragment into lexA pEG202
(45, 46) containing an EcoRI-BamHI adaptor
(5'-GATCCACCGATTCATCCATG-3' and 5'-AATTCATGGATGAATCGGTG-3'). Deletions
(dal82) were constructed by replacing WT sequences between
BamHI and XhoI of pVS827 with desired deletions
from the pRD and pSS series (Figs. 1 and 2). The
SphI-SphI fragment from p8202
(ADH1-lexA-DAL82) was cloned into pBTM116 (2µ-based) to
yield lexA-DAL82 pSS82BTM, containing TRP1.
pSH18-34 and pEG202 were used for transcriptional activation assays
(45, 46). All plasmids were verified by restriction and DNA sequence analyses.
Western Analysis, Enzymes, and EMSAs--
HA-dal82
(constructed by pSelect) replaced the WT gene in pRD41 (38), and the
resulting plasmids were expressed in E. coli strain
BL21(DE3) (47). Western transfer procedures were essentially as
described by Towbin et al. (48). HA-tagged antibody with horseradish peroxidase-conjugated secondary antibody (goat anti-mouse IgG; Bio-Rad) were used. EMSAs were performed using 10 µg of calf thymus + 50 ng of radiolabeled DNA fragment and 1-5 µg of protein (crude cell extract) (49). Urea amidolyase activity was determined in
nystatin-permeabilized cells/transformants (4, 50, 51).
Fluorescence Microscopy--
GYC86 cells transformed with pNVS2
or pNVS82 (grown overnight in medium containing 2% raffinose, 0.1%
ammonia, and yeast nitrogen base (+casamino acids)) was induced for
3 h (4% galactose) and viewed with epifluorescent and/or weak
white light using a Zeiss Axiophot microscope equipped with a
fluorescein or UV filter and an Optronics analogue camera.
4,6-Diamidino-2-phenylindole staining followed standard protocols
except that the cells were not fixed. Images were imported into
Photoshop Version 4.0. To evaluate co-localization, the
4,6-diamidino-2-phenylindole-positive staining was pseudo-colored red,
and the entire capture frame was merged with the GFP frame.
 |
RESULTS |
Localization of Dal82p--
Complementation of dal82
with GFP-DAL82 pNVS82 demonstrated that the fusion protein
retained native biological function (Table III). That only 2-fold induction occurred
in WT STCY32 was not disturbing because this parameter is both highly
strain- and gene-specific; for DAL7, induction ranges from
2- to 20-fold (26, 29). GFP pNVS2-transformed cells
exhibited uniform cytoplasmic fluorescence (Fig.
3N). GFP-DAL82
pNVS82 transformants fluoresced (Fig. 3, A-F, H,
and L) in a galactose-dependent manner (data not
shown). Superimposition of GFP and
4,6-diamidino-2-phenylindole-positive images indicated co-localization
(Fig. 3, G-M), supporting that GFP-Dal82p is specifically
nuclear. GFP-Dal82p localization was the same in WT and
dal81 strains whether or not inducer was present. Decreasing
the level of GAL1,10-GFP-DAL82 expression to the lower limit
of fluorescence detection by omitting galactose or shortening induction
to 1 h did not alter the results (data not shown).
View this table:
[in this window]
[in a new window]
|
Table III
GFP-DAL82 complementation of dal82
WT STCY32 and dal82 SS200 were transformed with
DAL7-lacZ reporter pHY43-1 (26); pSS20 (DAL82
under its own promoter), YCp50, or pSS423-82 was used for a second
transformation. -Galactosidase was assayed in transformants grown
(split culture) in medium containing 2% minimal glucose, 0.1%
proline, and yeast nitrogen base without amino acids or NH4 ± inducer, oxalurate (66 mg/liter). Note that the vector used for
microscopy (GAL1,10) and complementation (ADH1)
differed by the promoter driving GFP-DAL82 because the
strains used for the experiments were of necessity different;
dal82 mutant SS400 does not use galactose as sole carbon
source.
|
|

View larger version (95K):
[in this window]
[in a new window]
|
Fig. 3.
A-F, GFP-DAL82 expressed in
WT GYC86 cells. Co-localization of
4,6-diamidino-2-phenylindole-positive staining (I and
K, blue; and J and M,
pseudo-colored red) and GFP (H and L,
green) is indicated in yellow (J and
M). G, visible light only; N, GFP
vector expressed in the wild type.
|
|
DNA-binding Domain of Dal82p--
Dal82p was not homologous to any
known DNA-binding motifs. However, since Dal82p specifically binds to
UISALL (38), we prepared crude extracts from
E. coli BL21(DE3) transformants of HA-tagged dal82 plasmids (Fig. 2) and investigated the stability of
the mutant proteins. All extracts, except those from pT7-7 (vector), pRD4, and pSS495, contained proteins that could be easily detected by
Western blot analysis (Fig. 4); pRD41 and
pRD4 were the positive and negative controls (38). The extracts were
also used in EMSAs with DAL7 fragment JD72 ( 254 to 199),
containing a well characterized UISALL, as probe
(38) (see Fig. 5 for data and Fig. 2 for
a summary). A Dal82p-specific band ran close to the free DNA (Fig. 5,
lanes 2 and 5). This complex contains a stable
degradation product with the same binding specificity as full-length
Dal82p (38); it is clearer when less protein was assayed (Fig. 5,
lanes 7 and 8). These data argue that the first
85 Dal82p residues are sufficient for DNA binding.

View larger version (61K):
[in this window]
[in a new window]
|
Fig. 4.
Western blot analyses of extracts from
E. coli BL21(DE3) pLysS cells transformed with
HA-tagged Dal82p deletion derivatives. See Fig. 2 for maps.
|
|

View larger version (73K):
[in this window]
[in a new window]
|
Fig. 5.
EMSAs of truncated Dal82p. See Fig. 2.
The probe was the synthetic DNA fragment JD72 (38) containing a
DAL7 UISALL element. EXT, extract
omitted. Lane 8 contains 10 time more protein than
lane 7. Data are summarized in Fig. 2.
|
|
Transcriptional Activation Domain of Dal82p--
If Dal82p is the
UISALL-binding protein, then Dal81p might
complex to it and function as a transcriptional activator. By this reasoning, Dal82p might not contain a transcriptional activation motif
(53). Therefore, we transformed WT EGY48 cells with
lexA-lacZ transcriptional activation reporter pSH18-34,
pSH18-34 + vector pBTM116 (45, 46), or pSH18-34 + lexA-DAL82
pSS82BTM (15, 16). High level activation occurred only in
lexA-DAL82 pSS82BTM transformants (Fig.
6), indicating the ability of Dal82p to
support transcriptional activation. The only easily recognizable motif in Dal82p was a C-terminal coiled-coil. When it was deleted (pSH18-34 + pSS43), -galactosidase activity increased 5-fold (Fig. 6).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 6.
Gene activation supported by lexA
pBTM116, WT lexA-DAL82 pSS82BTM, or
lexA-dal82 pSS43 in strain M1682-19b
containing reporter pSH18-34. Transformants were grown in minimal
glucose/proline medium + oxalurate (66 mg/liter).
|
|
Two considerations prompted us to use the dal82 coiled-coil
deletion to investigate the activation domain. (i) It removes one
variable from the analysis; and (ii) increased activation permits
greater resolution of the genetic dissection. lacZ
expression was measured in EGY48 cells transformed with reengineered
lexA-dal82 plasmids (Fig.
7). Two regions were required for
activation: (i) an absolutely required core (residues 66-99) and (ii)
residues flanking it required only for full activity.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 7.
Reporter gene activation supported by
truncated Dal82p. dal82 mutants replaced WT sequences
in pVS827 (pEG202-derived). Transformants were in strain EGY48
containing pSH18-34 grown as described in the legend to Fig. 6.
|
|
Only Full-length Dal82p Is Able to Complement dal82 in
Vivo--
To determine whether the above constructs could complement
dal82 , SS400 cells were transformed with representative
plasmids, and urea amidolyase was measured. Urea amidolyase was highly
inducible only in a transformant containing WT pSS20 (Table
IV). The lack of complementation with
pSS43 is significant because the protein it encoded tested positive for
DNA binding and transcriptional activation. Measuring complementation
with DAL7-lacZ yielded similar results (Table IV);
DUR1,2 (encoding urea amidolyase) is always far more
inducible than DAL7 (8, 26, 37, 55).
View this table:
[in this window]
[in a new window]
|
Table IV
Complementation of dal82 by portions of DAL82
dal82 SS400 was the transformation recipient. The
deletion constructs replaced WT sequences in pSS20 and thus are under
the native DAL82 promoter. Culture conditions were as
described in the legend to Table III. Induction was for one generation
(30-60 Klett units). Urea amidolyase activity was assayed at a culture
density of 60 Klett units. DAL7-lacZ (pHY43-1) was the
reporter.
|
|
 |
DISCUSSION |
Our experiments argue that Dal82p is localized to the nucleus,
positively correlating with the in vitro demonstration that it binds to DNA. We were unable to obtain evidence that Dal82p localization is influenced by Dal81p or inducer. This possibility was
interesting in light of recent reports that Msn2p and Msn4p are
strongly regulated by controlling their entry into and exit from the
nucleus (54). Whether our lack of success in demonstrating an effect
was due to the overproduction of the protein required for us to see it
microscopically could not be determined because without some
overproduction, the fluorescent signal was too faint to see. Reducing
expression to the limit of detection, however, did not affect the results.
Three important regions were identified in Dal82p (Fig.
8). The DNA-binding domain consists of
residues 1-85. There is modest ambiguity in delineating the N terminus
of the domain because it was defined by pRD489 encoding a protein
lacking amino acids 8-16. It is unclear which of the first 16 residues
are necessary for function. The C terminus is tightly defined by pSS493
and pRD478 (Fig. 2). Although the Dal82p DNA-binding domain appears devoid of periodic structures and exhibits little similarity to known
DNA-binding motifs, amino acids 1-85 do share limited homology with
insect homeobox proteins HMEN (engrailed) and H17.

View larger version (6K):
[in this window]
[in a new window]
|
Fig. 8.
Schematic diagram of Dal82p indicating the
putative functional domains. ACT., activation domain.
|
|
The Dal82p domain required for transcriptional activation appears to be
more complex, consisting of residues 66-99 with the boundaries being
rather tightly defined. Flanking this region were residues whose
presence was not absolutely required, but they were nonetheless needed
to achieve high level activation. Without residues 32-66 and those in
the vicinity of positions 99-152, transcriptional activation reached
only one-third to one-fifth of the parental (pVS827) activity. When
residues 1-31 were removed, reporter gene expression decreased
20-40%.
The Dal82p DNA-binding and transcriptional activation domains overlap.
Since DNA binding involves a DNA-protein complex, whereas activation
probably involves a protein-protein interaction, this overlap might at
first seem a bit paradoxical. However, such data would be expected if
the N-terminal region of the protein is part of a domain whose
integrity is required for both DNA binding and transcriptional
activation. By this explanation, removing the non-overlapping portions
of the domain damages, but does not destroy, its ability to carry out
one of its functions. On the other hand, removing residues common to
both DNA binding and transcriptional activation distorts the putatively
shared domain to a point of losing all function. Consistent with this
speculation, most Dal82p preparations, including those in the above
experiments, are contaminated with a proteolytic product that more or
less comigrates with truncated Dal82p 85 amino acids long (Ref. 38 and
this work).
It appears that the N-terminal DNA-binding and activation domains are
able to function independently of the coiled-coil. We were, however,
surprised by the apparent negative role that the predicted coiled-coil
domain appears to play. Previously reported genetic results concerning
DAL82 led to the conclusion that it is a positive regulator.
However, removing the coiled-coil resulted in a 5-fold increase in
transcriptional activation ability, arguing in favor of it potentially
participating in a negative function as well. What is not clear at this
point is whether the coiled-coil interacts with another domain in
Dal82p or an unknown "repressor" protein to perform this function.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Harry Jarrett for the GFP
plasmid we used and the University of Tennessee Yeast Group, who
suggested improvements for the manuscript. Tim Higgins prepared the figures.
 |
FOOTNOTES |
*
The work was supported by United States Public Health
Service Grant GM-35642.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address: Dept. of Biochemistry and Microbiology, Rhodes
University, P. O. Box 94, Grahamstown 6140, South Africa.
§
Present address: Dept. of Oncology, McArdle Laboratory for Cancer
Research, University of Wisconsin, Madison, WI 53706.
¶
To whom correspondence should be addressed. Tel.:
901-448-6175; Fax: 901-448-8462; E-mail:
tcooper@utmem1.utmem.edu.
2
T. S. Cunningham, R. Anhare, and T. G. Cooper, manuscript in preparation.
 |
ABBREVIATIONS |
The abbreviations used are:
NCR, nitrogen
catabolite repression;
EMSAs, electrophoretic mobility shift assays;
PCR, polymerase chain reaction;
GFP, green fluorescent protein;
WT, wild-type;
HA, hemagglutinin.
 |
REFERENCES |
| 1.
|
Bysani, N.,
Daugherty, J. R.,
and Cooper, T. G.
(1991)
J. Bacteriol.
173,
4977-4982[Abstract/Free Full Text]
|
| 2.
|
Rai, R.,
Genbauffe, F. S.,
and Cooper, T. G.
(1987)
J. Bacteriol.
170,
266-271
|
| 3.
|
Rai, R.,
Genbauffe, F. S.,
and Cooper, T. G.
(1987)
J. Bacteriol.
169,
3521-3524[Abstract/Free Full Text]
|
| 4.
|
Rai, R.,
Genbauffe, F. S.,
Sumrada, R. A.,
and Cooper, T. G.
(1989)
Mol. Cell. Biol.
9,
602-608[Abstract/Free Full Text]
|
| 5.
|
Cooper, T. G.,
Rai, R.,
and Yoo, H. S.
(1989)
Mol. Cell. Biol.
9,
5440-5444[Abstract/Free Full Text]
|
| 6.
|
Cooper, T. G.
(1982)
in
The Molecular Biology of the Yeast Saccharomyces: Metabolism and Gene Expression
(Strathern, J. N.
, Jones, E. W.
, and Broach, J., eds)
, pp. 39-99, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 7.
|
Wiame, J.-M.,
Grenson, M.,
and Arst, H.
(1985)
Adv. Microb. Physiol.
26,
1-87[Medline]
[Order article via Infotrieve]
|
| 8.
|
Cooper, T. G.
(1994)
in
Mycota
(Marzluf, G.
, and Bambrl, R., eds), Vol. III
, pp. 139-169, Springer-Verlag, Berlin
|
| 9.
|
Cooper, T. G.,
and Sumrada, R. A.
(1983)
J. Bacteriol.
155,
623-627[Abstract/Free Full Text]
|
| 10.
|
Cooper, T. G.,
Ferguson, D.,
Rai, R.,
and Bysani, N.
(1990)
J. Bacteriol.
172,
1014-1018[Abstract/Free Full Text]
|
| 11.
|
Minehart, P. L.,
and Magasanik, B.
(1991)
Mol. Cell. Biol.
11,
6216-6228[Abstract/Free Full Text]
|
| 12.
|
Blinder, D.,
and Magasanik, B.
(1995)
J. Bacteriol.
177,
4190-4193[Abstract/Free Full Text]
|
| 13.
|
Stanbrough, M.,
Rowen, D. W.,
and Magasanik, B.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
9450-9454[Abstract/Free Full Text]
|
| 14.
|
Coffman, J. A.,
Rai, R.,
and Cooper, T. G.
(1995)
J. Bacteriol.
177,
6910-6918[Abstract/Free Full Text]
|
| 15.
|
Coffman, J. A.,
Rai, R.,
Cunningham, T. S.,
Svetlov, V.,
and Cooper, T. G.
(1996)
Mol. Cell. Biol.
16,
847-858[Abstract]
|
| 16.
|
Cunningham, T. S.,
Svetlov, V.,
Rai, R.,
and Cooper, T. G.
(1995)
J. Bacteriol.
178,
3470-3479[Abstract/Free Full Text]
|
| 17.
|
Daugherty, J. R.,
Rai, R.,
ElBerry, H. M.,
and Cooper, T. G.
(1993)
J. Bacteriol.
175,
64-73[Abstract/Free Full Text]
|
| 18.
|
Minehart, P. L.,
and Magasanik, B.
(1992)
J. Bacteriol.
174,
1828-1836[Abstract/Free Full Text]
|
| 19.
|
Chisholm, G.,
and Cooper, T. G.
(1982)
Mol. Cell. Biol.
2,
1088-1095[Abstract/Free Full Text]
|
| 20.
|
Coffman, J. A.,
Rai, R.,
Loprete, D. M.,
Cunningham, T.,
Svetlov, V.,
and Cooper, T. G.
(1997)
J. Bacteriol.
179,
3416-3429[Abstract/Free Full Text]
|
| 21.
|
Cunningham, T. S.,
Dorrington, R. A.,
and Cooper, T. G.
(1994)
J. Bacteriol.
176,
4718-4725[Abstract/Free Full Text]
|
| 22.
|
Galibert, F.
(1996)
EMBO J.
15,
2031-2049[Medline]
[Order article via Infotrieve]
|
| 23.
|
Soussi-Boudekou, S.,
Vissers, S. S.,
Urrestarazu, A.,
Jauniaux, J.-C.,
and Andre, B.
(1997)
Mol. Microbiol.
23,
1157-1168[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Cunningham, T. S.,
and Cooper, T. G.
(1993)
J. Bacteriol.
175,
5851-5861[Abstract/Free Full Text]
|
| 25.
|
Andre, B.,
Talibi, D.,
Boudekou, S. S.,
Hein, C.,
Vissers, S.,
and Coornaert, D.
(1995)
Nucleic Acids Res.
23,
558-564[Abstract/Free Full Text]
|
| 26.
|
Yoo, H. S.,
and Cooper, T. G.
(1989)
Mol. Cell. Biol.
9,
3231-3243[Abstract/Free Full Text]
|
| 27.
|
Yoo, H. S.,
and Cooper, T. G.
(1991)
Gene (Amst.)
104,
55-62[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Hartig, A.,
Simon, M. M.,
Schuster, T.,
Daugherty, J. R.,
Yoo, H. S.,
and Cooper, T. G.
(1992)
Nucleic Acids Res.
20,
5677-5686[Abstract/Free Full Text]
|
| 29.
|
Park, H. D.,
Scott, S.,
Rai, R.,
Dorrington, R.,
and Cooper, T. G.
(1999)
J. Bacteriol.
181,
7052-7064[Abstract/Free Full Text]
|
| 30.
|
Van Vuuren, H. J. J.,
Daugherty, J. R.,
Rai, R.,
and Cooper, T. G.
(1991)
J. Bacteriol.
173,
7186-7195[Abstract/Free Full Text]
|
| 31.
|
Turoscy, V.,
and Cooper, T. G.
(1982)
J. Bacteriol.
151,
1237-1246[Abstract/Free Full Text]
|
| 32.
|
Vissers, S.,
Andre, B.,
Muyldermansm, F.,
and Grenson, M.
(1989)
Eur. J. Biochem.
181,
357-361[Medline]
[Order article via Infotrieve]
|
| 33.
|
Lemoine, Y.,
Dubois, E.,
and Wiame, J.-M.
(1978)
Mol. Gen. Genet.
166,
251-258[Medline]
[Order article via Infotrieve]
|
| 34.
|
Olive, M. J.,
Daugherty, J. R.,
and Cooper, T. G.
(1991)
J. Bacteriol.
173,
255-261[Abstract/Free Full Text]
|
| 35.
|
Bricmont, P. A.,
and Cooper, T. G.
(1989)
Mol. Cell. Biol.
9,
3869-3877[Abstract/Free Full Text]
|
| 36.
|
Bricmont, P. A.,
Daugherty, J. R.,
and Cooper, T. G.
(1991)
Mol. Cell. Biol.
11,
1161-1166[Abstract/Free Full Text]
|
| 37.
|
Genbauffe, F. S.,
and Cooper, T. G.
(1986)
Mol. Cell. Biol.
6,
3954-3964[Abstract/Free Full Text]
|
| 38.
|
Dorrington, R. A.,
and Cooper, T. G.
(1993)
Nucleic Acids Res.
21,
3777-3784[Abstract/Free Full Text]
|
| 39.
|
Sikorski, R. S.,
and Heiter, P.
(1989)
Genetics
122,
19-27[Abstract/Free Full Text]
|
| 40.
|
Mitchell, D. A.,
Marshall, T. K.,
and Deschenes, R. J.
(1993)
Yeast
9,
715-722[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Jarrett, H. W.,
and Taylor, W. L.
(1998)
J. Chromatogr.
803,
131-139[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Allen, J. B.,
and Elledge, S. J.
(1994)
Yeast
10,
1267-1272[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Christianson, T. W.,
Sikorski, R. S.,
Dante, M.,
Shero, J. H.,
and Heiter, P.
(1992)
Gene (Amst.)
110,
119-122[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Alani, E.,
Cao, L.,
and Kleckner, N.
(1987)
Genetics
116,
541-545[Abstract/Free Full Text]
|
| 45.
|
Golemis, E. A.,
Gyuris, J.,
and Brent, R.
(1996)
in
Current Protocols in Molecular Biology
(Ausabel, F. M.
, Brent, R.
, Kingston, R.
, Moore, D.
, Seidman, J.
, and Struhl, K., eds)
, John Wiley & Sons, Inc., New York
|
| 46.
|
Bartel, P.,
Chien, C.,
Sternglanz, R.,
and Fields, S.
(1993)
in
Cellular Interactions in Development: A Practical Approach
(Hartley, D. A., ed)
, pp. 153-179, Oxford University Press, Oxford
|
| 47.
|
Dubendorff, J. W.,
and Studier, F. W.
(1992)
J. Mol. Biol.
219,
45-59
|
| 48.
|
Towbin, H.,
Stachelin, T.,
and Gordon, J.
(1992)
Biotechnology
24,
145-149[Medline]
[Order article via Infotrieve]
|
| 49.
|
Luche, R. M.,
Sumrada, R.,
and Cooper, T. G.
(1990)
Mol. Cell. Biol.
10,
3884-3895[Abstract/Free Full Text]
|
| 50.
|
Whitney, P. A.,
Cooper, T. G.,
and Magasanik, B.
(1973)
J. Biol. Chem.
248,
6203-6209[Abstract/Free Full Text]
|
| 51.
|
Miller, J. H.
(1972)
Experiments in Molecular Genetics
, p. 403, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 52.
|
Kunze, I.,
Adler, H. G.,
Bernard, J.,
Nilsson, N. B.,
Stoltenburg, R.,
Kohlvein, S. D.,
and Kunze, G.
(1999)
Biochim. Biophys. Acta
410,
287-298
|
| 53.
|
Svetlov, V.,
and Cooper, T. G.
(1997)
J. Bacteriol.
179,
7644-7652[Abstract/Free Full Text]
|
| 54.
|
Gorner, W.,
Durchschlag, E.,
Martinez-Pastor, M. T.,
Estruch, F.,
Ammerer, G.,
Hamilton, B.,
Ruis, H.,
and Schuller, T.
(1998)
Genes Dev.
12,
586-597[Abstract/Free Full Text]
|
| 55.
|
Roon, R. J.,
and Levenberg, B.
(1968)
J. Biol. Chem.
243,
5213-5215[Abstract/Free Full Text]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Boban and P. O. Ljungdahl
Dal81 Enhances Stp1- and Stp2-Dependent Transcription Necessitating Negative Modulation by Inner Nuclear Membrane Protein Asi1 in Saccharomyces cerevisiae
Genetics,
August 1, 2007;
176(4):
2087 - 2097.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Distler, A. Kulkarni, R. Rai, and T. G. Cooper
Green Fluorescent Protein-Dal80p Illuminates up to 16 Distinct Foci That Colocalize with and Exhibit the Same Behavior as Chromosomal DNA Proceeding through the Cell Cycle of Saccharomyces cerevisiae
J. Bacteriol.,
August 1, 2001;
183(15):
4636 - 4642.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. S. Cunningham, R. Andhare, and T. G. Cooper
Nitrogen Catabolite Repression of DAL80 Expression Depends on the Relative Levels of Gat1p and Ure2p Production in Saccharomyces cerevisiae
J. Biol. Chem.,
May 5, 2000;
275(19):
14408 - 14414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. H. Cox, R. Rai, M. Distler, J. R. Daugherty, J. A. Coffman, and T. G. Cooper
Saccharomyces cerevisiae GATA Sequences Function as TATA Elements during Nitrogen Catabolite Repression and When Gln3p Is Excluded from the Nucleus by Overproduction of Ure2p
J. Biol. Chem.,
June 2, 2000;
275(23):
17611 - 17618.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Scott, A. T. Abul-Hamd, and T. G. Cooper
Roles of the Dal82p Domains in Allophanate/Oxalurate-dependent Gene Expression in Saccharomyces cerevisiae
J. Biol. Chem.,
September 29, 2000;
275(40):
30886 - 30893.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Kulkarni, A. T. Abul-Hamd, R. Rai, H. El Berry, and T. G. Cooper
Gln3p Nuclear Localization and Interaction with Ure2p in Saccharomyces cerevisiae
J. Biol. Chem.,
August 17, 2001;
276(34):
32136 - 32144.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|